These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8529811)

  • 1. Acute cardiotoxicity of the Anti-HIV dideoxynucleoside, F-ddA, in the rat.
    Donzanti BA; Kelley JA; Tomaszewski JE; Roth JS; Tosca P; Placke M; Singer A; Yarrington JT; Driscoll JS
    Fundam Appl Toxicol; 1995 Sep; 27(2):167-76. PubMed ID: 8529811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of brain tissue localized purine metabolizing enzymes in the central nervous system delivery of anti-HIV agents 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
    Singhal D; Morgan ME; Anderson BD
    Pharm Res; 1997 Jun; 14(6):786-92. PubMed ID: 9210198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of altered metabolism in dideoxynucleoside pharmacokinetics. Studies of 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
    Singhal D; Morgan ME; Anderson BD
    Drug Metab Dispos; 1996 Oct; 24(10):1155-61. PubMed ID: 8894519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute cardiotoxicity of nucleoside analogs FddA and FddI in rats.
    Comereski CR; Kelly WA; Davidson TJ; Warner WA; Hopper LD; Oleson FB
    Fundam Appl Toxicol; 1993 Apr; 20(3):360-4. PubMed ID: 8504910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2'-beta-fluoro-2',3'-dideoxyadenosine, lodenosine, in rhesus monkeys: plasma and cerebrospinal fluid pharmacokinetics and urinary disposition.
    Roth JS; McCully CM; Balis FM; Poplack DG; Kelley JA
    Drug Metab Dispos; 1999 Oct; 27(10):1128-32. PubMed ID: 10497138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced oral bioavailability of 2'- beta-fluoro-2',3'-dideoxyadenosine (F-ddA) through local inhibition of intestinal adenosine deaminase.
    DeGraw RT; Anderson BD
    Pharm Res; 2001 Sep; 18(9):1270-6. PubMed ID: 11683239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro induction of human immunodeficiency virus type 1 variants resistant to 2'-beta-Fluoro-2',3'-dideoxyadenosine.
    Tanaka M; Srinivas RV; Ueno T; Kavlick MF; Hui FK; Fridland A; Driscoll JS; Mitsuya H
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1313-8. PubMed ID: 9174190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of 2'-beta-fluoro-2',3'-dideoxyadenosine, an experimental anti-AIDS drug, in human plasma by high-performance liquid chromatography.
    Roth JS; Ford H; Tanaka M; Mitsuya H; Kelley JA
    J Chromatogr B Biomed Sci Appl; 1998 Aug; 712(1-2):199-210. PubMed ID: 9698243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of anti-HIV 2'-beta-fluoro-2',3'-dideoxynucleoside analogs on the cellular content of mitochondrial DNA and on lactate production.
    Tsai CH; Doong SL; Johns DG; Driscoll JS; Cheng YC
    Biochem Pharmacol; 1994 Oct; 48(7):1477-81. PubMed ID: 7945448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics of new anti-HIV agents: 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
    Russell JW; Klunk LJ
    Biochem Pharmacol; 1989 May; 38(9):1385-8. PubMed ID: 2497744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of carrier-mediated transport of 2',3'-dideoxypurine nucleosides in the rat ileum using a bidirectional perfusion technique.
    DeGraw RT; Anderson BD
    Pharm Res; 2004 Feb; 21(2):300-8. PubMed ID: 15032312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine in mice.
    el Dareer SM; Tillery KF; Kalin JR; Hill DL
    Invest New Drugs; 1989 Jul; 7(2-3):139-46. PubMed ID: 2507472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of lodenosine and its major metabolite in human plasma by liquid chromatography/electrospray ionization tandem mass spectrometry.
    Roth JS; Wang J; Kelley JA
    J Mass Spectrom; 2000 Nov; 35(11):1313-9. PubMed ID: 11114090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. F-ddA for HIV.
    Treat Rev; 1996 Aug; (No 22):10. PubMed ID: 11363812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of 6-azido-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosylpurine and N6-methyl-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosyladenine as prodrugs of the anti-HIV nucleosides 2'-F-ara-ddA and 2'-F-ara-ddI.
    Koudriakova T; Manouilov KK; Shanmuganathan K; Kotra LP; Boudinot FD; Cretton-Scott E; Sommadossi JP; Schinazi RF; Chu CK
    J Med Chem; 1996 Nov; 39(23):4676-81. PubMed ID: 8917656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High performance liquid chromatography analysis of 9-(2',3'-dideoxy-2'beta-fluoro-D-threo-penta furanosyl) adenine and its metabolite in human plasma using solid-phase extraction on a polyfluorinated reversed stationary phase.
    Aboul-Enein HY; Abu-Zaid S
    Biomed Chromatogr; 2001 Jun; 15(4):267-70. PubMed ID: 11438969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism in human leukocytes of anti-HIV dideoxypurine nucleosides.
    Fridland A; Johnson MA; Cooney DA; Ahluwalia G; Marquez VE; Driscoll JS; Johns DG
    Ann N Y Acad Sci; 1990; 616():205-16. PubMed ID: 2078020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cycloSal-Pronucleotides of 2'-fluoro-ara- and 2'-fluoro-ribo-2',3'- dideoxyadenosine as a strategy to bypass a metabolic blockade.
    Meier C; Knispel T; Marquez VE; Siddiqui MA; De Clercq E; Balzarini J
    J Med Chem; 1999 May; 42(9):1615-24. PubMed ID: 10229630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the DNA incorporation in human MOLT-4 cells of two 2'-beta-fluoronucleosides, 2'-beta-fluoro-2',3'-dideoxyadenosine and fialuridine.
    Ahluwalia GS; Driscoll JS; Ford H; Johns DG
    J Pharm Sci; 1996 Apr; 85(4):454-5. PubMed ID: 8901088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a fluorogenic derivatization method for the reversed-phase HPLC analysis of 2'-beta-fluoro-2',3'-dideoxyadenosine, a new anti-AIDS drug.
    Zhang H; Ford H; Roth JS; Kelley JA
    J Pharm Biomed Anal; 2001 May; 25(2):285-97. PubMed ID: 11275436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.